http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100761675-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate | 1999-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100761675-B1 |
| titleOfInvention | Preparation for administration of hepatic parenchymal cell growth factor |
| abstract | The present invention relates to a formulation for administration for containing or treating hepatic parenchymal cell growth factor (HGF) as an active ingredient for treating or preventing ischemic diseases or arterial diseases.n n n Compared to intravenous administration, the HGF concentration of the HGF-administered lesion is maintained to have a long half-life and a reduced dose, and also has an effect of less action on the lesion.n n n n Liver parenchymal cell proliferation factor (HGF), intramuscular administration, ischemic disease, arterial disease, half-life |
| priorityDate | 1998-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.